About ACI Clinical
ACI Clinical is a Healthcare company based in Bala Cynwyd (United States) founded in 2001, and was acquired by WIRB-Copernicus Group in March 2018. Expert committee management services are provided for clinical research. ACI Clinical offers products and services including AIMS®, Connexus, and IRBNet. Its focus areas include Biopharma Outsourcing, CRO, Clinical Development and Functional Services. Its competitors include SSI Strategy, Health Decisions and Antios Therapeutics; 1 of its 3 listed competitors has raised funding.
Company details
ACI Clinical offers advisory services to manage independently managed expert committees in clinical research. They specialize in offering their services for independent committees on endpoint adjudication, data monitoring and safety assessment. The company claims to have supported more than 600 projects for more than 100 compounds for pharma, biotech, academia, medical device companies and CROs in almost all therapeutic areas.The company offers proprietary software solutions such as AIMS (Adjudication Information Management System), which are built exclusively for committee management. ACI Clinical also offers solutions for the automated workflow management of the Data Monitoring Committee and data standardization as per CDISC standards for regulatory submissions. The company claims to have a network of 500 medical, statistical and safety experts who can serve as committee members andor advisors. They also offer expert management services such as identification and qualification of candidates and rate negotiation and contracting.
- Headquarters Bala Cynwyd, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website aciclinical.com
- Social LinkedIn Facebook
- Acquired by WIRB-Copernicus Group (Mar 2018)
- Investors
- Acquired byWIRB-Copernicus Group
(Mar 2018)
Products & Services of ACI Clinical
ACI Clinical offers a comprehensive portfolio of products and services, including AIMS®, Connexus, and IRBNet.
Platform for managing endpoint adjudication in clinical trials.
Tool for IRB and IBC ethical review processes.
System for study review and documentation support.
Investors in ACI Clinical
ACI Clinical has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include WIRB-Copernicus Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Regulatory and ethical review services for clinical research are provided. | 2012 | wcgclinical.com | Princeton, United States |
Investor details for ACI Clinical
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ACI Clinical
379 people are tracked at ACI Clinical (134 in leadership, 1 in board & advisors, 244 in team).
| Name | Role | Group |
|---|---|---|
Russell John | Senior Director, Business Intelligence And Benchmarking | Leadership |
Ron Thornton | Vice President Of Business Development And General Manager Of Velos, LLC | Leadership |
Jared Zane | Chief Legal Officer & Corporate Secretary | Leadership |
Jill Johnston | Chief Innovation Officer | Leadership |
Paul Halas | Director Of Business Development | Leadership |
Jillian Milam | Director Of Business Development | Leadership |
McPaul Ogbonna | Director, Business Development | Data Analytics & Consulting | Leadership |
Geoffrey Schick Mba, Chrc | Director, Strategic Site Partnerships | Leadership |
Daniel F. | Associate Director, Project Governance | Leadership |
Stacey Rumerman | Senior Director, Clinical Science | Leadership |
Joseph Mumma | Vice President, Quality Assurance, Technology | Leadership |
Jessica Blankenship | Senior Director, Quality | Leadership |
Sana Ansari | Director, Business Development | Leadership |
Sam Srivastava | Chief Executive Officer | Leadership |
Robert Vanhees | CFO & Chief Administrative Officer | Leadership |
Carmin Gade | Chief Marketing Officer | Leadership |
Lisa Calicchio | Chief Human Capital Management Officer | Leadership |
Mark McDonald | President, Ethical Review Division, WCG | Leadership |
Alexandra de Jong | Director Of Platform Governance And Operational Excellence | Leadership |
Wasim C. | Clinical Trial Solutions Partner | Leadership |
359 more people are available in the full profile.
Complete people profiles for ACI Clinical
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of ACI Clinical
2 dated milestones of ACI Clinical across 17 years, from founding to its latest funding, stage changes and deals.
- Founded ACI Clinical is founded.
- Exit Acquired by WIRB-Copernicus Group.
Competitors of ACI Clinical
ACI Clinical has 3 listed competitors in our database, 1 of them funded. They include SSI Strategy, Health Decisions and Antios Therapeutics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| ssistrategy.com | 2010 | Parsippany Troy Hills, United States | Pharmacovigilance and medical affairs services are offered for drug development. | |||
| healthdec.com | 1989 | Durham, United States | 110 | CRO focused on clinical trial services for data management, monitoring and biostatistics | ||
| antiostherapeutics.com | 2018 | Atlanta, United States | $200.4M | Innovative therapies for treating and curing viral diseases are developed. |
Detailed competitors of ACI Clinical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ACI Clinical (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Aci Clinical
Complete news archive for ACI Clinical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ACI Clinical
ACI Clinical was founded in 2001.
ACI Clinical is headquartered in Bala Cynwyd, United States. It is registered at Bala Cynwyd, Pennsylvania, United States.
ACI Clinical offers advisory services to manage independently managed expert committees in clinical research. They specialize in offering their services for independent committees on endpoint adjudication, data monitoring and safety assessment. The company claims to have supported more than 600 projects for more than 100 compounds for pharma, biotech, academia, medical device companies and CROs in almost all therapeutic areas.The company offers proprietary software solutions such as AIMS (Adjudication Information Management System), which are built exclusively for committee management. ACI Clinical also offers solutions for the automated workflow management of the Data Monitoring Committee and data standardization as per CDISC standards for regulatory submissions. The company claims to have a network of 500 medical, statistical and safety experts who can serve as committee members andor advisors. They also offer expert management services such as identification and qualification of candidates and rate negotiation and contracting.
ACI Clinical's top competitors include SSI Strategy, Health Decisions and Antios Therapeutics.
ACI Clinical offers AIMS®, Connexus, and IRBNet.
ACI Clinical has 1 investor. Key investors include WIRB-Copernicus Group.
Yes. ACI Clinical was acquired by WIRB-Copernicus Group in March 2018.